Scarica l'app Stockscreener
4.25
7.61%
-0.35
Dopo l'orario di chiusura:
4.10
-0.15
-3.53%
Precedente Chiudi:
$4.60
Aprire:
$4.48
Volume 24 ore:
245.90K
Relative Volume:
0.82
Capitalizzazione di mercato:
$2.17M
Reddito:
$4.70M
Utile/perdita netta:
$-4.99M
Rapporto P/E:
-0.662
EPS:
-6.42
Flusso di cassa netto:
$-5.29M
1 W Prestazione:
-2.52%
1M Prestazione:
-25.31%
6M Prestazione:
-57.82%
1 anno Prestazione:
-83.43%
Intervallo 1D:
$4.14
$4.50
Intervallo di 1 settimana:
$3.86
$4.66
Portata 52W:
$3.64
$108.00
Salarius Pharmaceuticals Inc Stock (SLRX) Company Profile
Nome
Salarius Pharmaceuticals Inc
Settore
Industria
Telefono
346-772-0346
Indirizzo
2450 HOLCOMBE BLVD, HOUSTON
Confronta SLRX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
SLRX
Salarius Pharmaceuticals Inc
|
4.25 | 3.94M | 4.70M | -4.99M | -5.29M | -6.42 |
|
VRTX
Vertex Pharmaceuticals Inc
|
408.61 | 105.69B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
481.07 | 61.52B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
569.17 | 60.69B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
837.28 | 50.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
318.02 | 35.25B | 4.56B | -176.77M | 225.30M | -1.7177 |
Salarius Pharmaceuticals Inc Stock (SLRX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2020-04-27 | Iniziato | Ladenburg Thalmann | Buy |
Salarius Pharmaceuticals Inc Borsa (SLRX) Ultime notizie
How institutional ownership impacts Salarius Pharmaceuticals Inc. stockJuly 2025 Pullbacks & Weekly High Return Opportunities - newser.com
Intraday pattern recognizer results for Salarius Pharmaceuticals Inc.Trade Volume Report & Risk Adjusted Swing Trade Ideas - newser.com
Can machine learning forecast Salarius Pharmaceuticals Inc. recoveryWeekly Loss Report & Safe Capital Growth Tips - newser.com
Will Salarius Pharmaceuticals Inc. stock benefit from green energy trends2025 EndofYear Setup & Intraday High Probability Alerts - newser.com
How to recover losses in Salarius Pharmaceuticals Inc. stockJuly 2025 Volume & Fast Exit and Entry Strategy Plans - newser.com
Salarius Pharma Stock Jumps After-Hours As Nasdaq Compliance Clears Path For Decoy Merger — Retail Bulls Bet On Breakout - Stocktwits
Salarius Pharmaceuticals Regains Nasdaq Compliance - TradingView
Applying Elliott Wave Theory to Salarius Pharmaceuticals Inc.2025 Trading Recap & Capital Efficiency Focused Ideas - newser.com
How higher bond yields impact Salarius Pharmaceuticals Inc. (FP10) stockCPI Data & Weekly Setup with High ROI Potential - newser.com
Real time alert setup for Salarius Pharmaceuticals Inc. performanceRisk Management & Verified Technical Signals - newser.com
Salarius Pharmaceuticals Regains Compliance with Nasdaq Listing Requirements Ahead of Merger with Decoy Therapeutics - Quiver Quantitative
Salarius Pharmaceuticals Regains Compliance with All Nasdaq Listing Requirements - GlobeNewswire
Can Salarius Pharmaceuticals Inc. stock deliver sustainable ROETrade Volume Report & Weekly Return Optimization Alerts - newser.com
Salarius Pharmaceuticals Inc. stock momentum explainedTrade Ideas & Expert Curated Trade Ideas - newser.com
Long term hold vs stop loss in Salarius Pharmaceuticals Inc.July 2025 Catalysts & Weekly Momentum Picks - newser.com
What data driven models say about Salarius Pharmaceuticals Inc.’s futureJuly 2025 Big Picture & Low Drawdown Investment Ideas - newser.com
Is Salarius Pharmaceuticals Inc. (FP10) stock positioned for secular growth2025 Risk Factors & Consistent Profit Trading Strategies - newser.com
Why Salarius Pharmaceuticals Inc. (FP10) stock could break out in 2025Quarterly Market Review & Momentum Based Trading Signals - newser.com
Ewing Sarcoma Market Report 2034: Epidemiology Insights, Pipeline Developments, and Key Regulatory Approvals (FDA, EMA, PMDA) | Published by DelveInsight | Featuring Leading Companies: Salarius Pharma - Barchart.com
Salarius Pharmaceuticals (NASDAQ:SLRX) Trading 1% Higher – Here’s Why - Defense World
Salarius Pharmaceuticals Awaits Nasdaq Compliance Confirmation - TipRanks
What Fibonacci levels say about Salarius Pharmaceuticals Inc. reboundQuarterly Trade Review & Capital Efficient Trade Techniques - newser.com
Exit strategy if you’re trapped in Salarius Pharmaceuticals Inc.Market Movers & Daily Volume Surge Trade Alerts - newser.com
Risk vs reward if holding onto Salarius Pharmaceuticals Inc.July 2025 Technicals & Safe Entry Trade Reports - newser.com
Is Salarius Pharmaceuticals Inc. building a consolidation baseWeekly Stock Recap & Technical Buy Zone Confirmations - newser.com
Should you wait for a breakout in Salarius Pharmaceuticals Inc.2025 Market Outlook & Safe Capital Growth Tips - newser.com
What momentum shifts mean for Salarius Pharmaceuticals Inc.2025 Price Action Summary & Weekly Chart Analysis and Trade Guides - newser.com
Salarius Pharmaceuticals Inc Azioni (SLRX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.96%
0.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):